De Rucci Healthy Sleep Co., Ltd. (SHE:001323)

De Rucci Healthy Sleep Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	5,405	5,522	5,516	5,757	6,416	4,420
Other Revenue	80.7	80.7	62.35	55.31	64.86	32.82
Revenue	5,486	5,603	5,579	5,813	6,481	4,452
Revenue Growth (YoY)	-2.92%	0.43%	-4.03%	-10.31%	45.56%	15.29%
Cost of Revenue	2,687	2,802	2,775	3,113	3,568	2,262
Gross Profit	2,799	2,801	2,803	2,699	2,913	2,191
Selling, General & Admin	1,813	1,713	1,709	1,769	1,911	1,394
Research & Development	214.76	205.28	185.76	158.29	155.08	90.35
Other Operating Expenses	46.03	40.51	36.3	46.99	46.81	36.92
Operating Expenses	2,082	1,961	1,928	1,981	2,116	1,522
Operating Income	717.43	840.48	875.48	718.6	797.17	668.64
Interest Expense	-20.15	-17.88	-8.79	-9.28	-10.85	-2.6
Interest & Investment Income	56.85	65.88	73.24	58.83	39.77	7.8
Currency Exchange Gain (Loss)	-4.13	-4.13	0.83	-5.34	-6.55	4.15
Other Non Operating Income (Expenses)	-5.98	-2.98	-8.59	-8.25	-9.1	-8.32
EBT Excluding Unusual Items	744.03	881.38	932.17	754.56	810.44	669.68
Gain (Loss) on Sale of Investments	68.75	21.42	0.39	0.74	-	-0.09
Gain (Loss) on Sale of Assets	1.76	-8	7.17	29.31	-4.52	-0.69
Asset Writedown	-2.37	-1.4	-7.41	-1.11	-0.39	-4.05
Other Unusual Items	25.34	25.34	26.98	35.91	10.28	-3.81
Pretax Income	837.5	918.73	959.31	819.4	817.82	662.89
Income Tax Expense	127.97	151.4	157.04	111	131.37	126.58
Earnings From Continuing Operations	709.53	767.33	802.27	708.41	686.44	536.3
Minority Interest in Earnings	2.4	-	-	-	-	0.03
Net Income	711.92	767.33	802.27	708.41	686.44	536.34
Net Income to Common	711.92	767.33	802.27	708.41	686.44	536.34
Net Income Growth	-11.70%	-4.35%	13.25%	3.20%	27.99%	61.06%
Shares Outstanding (Basic)	431	433	439	419	395	351
Shares Outstanding (Diluted)	431	433	439	419	395	351
Shares Change (YoY)	-1.35%	-1.41%	4.80%	5.98%	12.57%	-
EPS (Basic)	1.65	1.77	1.83	1.69	1.74	1.53
EPS (Diluted)	1.65	1.77	1.83	1.69	1.74	1.53
EPS Growth	-10.49%	-2.99%	8.07%	-2.62%	13.69%	-
Free Cash Flow	618.2	709.84	1,539	25.7	226.43	530.18
Free Cash Flow Per Share	1.44	1.64	3.50	0.06	0.57	1.51
Dividend Per Share	1.359	1.591	0.909	1.818	-	-
Dividend Growth	-14.57%	75.00%	-50.00%	-	-	-
Gross Margin	51.03%	49.99%	50.25%	46.44%	44.94%	49.20%
Operating Margin	13.08%	15.00%	15.69%	12.36%	12.30%	15.02%
Profit Margin	12.98%	13.70%	14.38%	12.19%	10.59%	12.05%
Free Cash Flow Margin	11.27%	12.67%	27.59%	0.44%	3.49%	11.91%
EBITDA	936.15	1,049	1,069	893.41	925.05	746.43
EBITDA Margin	17.06%	18.71%	19.17%	15.37%	14.27%	16.77%
D&A For EBITDA	218.72	208.1	193.93	174.81	127.89	77.79
EBIT	717.43	840.48	875.48	718.6	797.17	668.64
EBIT Margin	13.08%	15.00%	15.69%	12.36%	12.30%	15.02%
Effective Tax Rate	15.28%	16.48%	16.37%	13.55%	16.06%	19.10%
Revenue as Reported	5,486	5,603	5,579	5,813	6,481	-
Advertising Expenses	-	768.93	753.11	756.49	831.77	588.93

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.